(Q39572340)

13 September 2017

title

Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin (English)

1 reference

13 September 2017

1 reference

Fiorella Petronzelli

1

1 reference

13 September 2017

Anna M Anastasi

2

1 reference

13 September 2017

Angela Pelliccia

3

1 reference

13 September 2017

Daniela Santapaola

4

1 reference

13 September 2017

Claudio Albertoni

5

1 reference

13 September 2017

Antonio Rosi

6

1 reference

13 September 2017

Barbara Leoni

7

1 reference

13 September 2017

Liliana E Ferrari

8

1 reference

13 September 2017

Giovanni Paganelli

9

1 reference

13 September 2017

Giancarlo Gramiccioli

10

1 reference

13 September 2017

Daniela Pesce

11

1 reference

13 September 2017

Anna M Alfano

12

1 reference

13 September 2017

Maria A Stasi

13

1 reference

13 September 2017

Rita De Santis

14

1 reference

13 September 2017

publication date

25 April 2011

1 reference

Basic and Clinical Pharmacology and Toxicology

13 September 2017

published in

1 reference

13 September 2017

volume

109

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

145-155

1 reference

Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

AVIDIN. 2. PURIFICATION AND COMPOSITION

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

OXavidin for tissue targeting biotinylated therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

AvidinOX for highly efficient tissue-pretargeted radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

The properties of streptavidin, a biotin-binding protein produced by Streptomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Revised methods for the Salmonella mutagenicity test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Natural antibodies to avidin in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Cell Cycle Redistribution as a Factor in Multifraction Irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Some cases of severe normal tissue toxicity can be anticipated with ablated fractionated radiation with appropriate long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

Toxic and drug-induced myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2011.00701.X

10.1111/J.1742-7843.2011.00701.X

21 January 2018

Identifiers

DOI

1 reference

release_mcdntfbzyba4lnh3wtzksdr4pm

13 September 2017

Fatcat ID

0 references

1 reference